| Primary |
|
| Limb Deformity |
50.0% |
| Nausea |
50.0% |
|
| Secondary |
| Fibromyalgia |
29.5% |
| Pain |
17.2% |
| Hypertension |
10.3% |
| Depression |
8.4% |
| Blood Cholesterol Increased |
6.5% |
| Insomnia |
5.2% |
| Anxiety |
4.9% |
| Systemic Lupus Erythematosus |
3.4% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Hormone Replacement Therapy |
1.7% |
| Blood Pressure Increased |
1.3% |
| Osteopenia |
1.3% |
| Panic Disorder |
1.3% |
| Schizophrenia |
1.3% |
| Urinary Tract Infection |
1.3% |
| Product Used For Unknown Indication |
1.1% |
| Hypersensitivity |
0.9% |
| Nervousness |
0.9% |
| Osteoporosis |
0.9% |
| Drug Use For Unknown Indication |
0.6% |
|
| Insomnia |
19.4% |
| Serotonin Syndrome |
16.5% |
| Mental Status Changes |
11.7% |
| Potentiating Drug Interaction |
11.7% |
| Vision Blurred |
5.8% |
| Rash |
4.9% |
| Dizziness |
3.9% |
| Tremor |
3.9% |
| Ventricular Tachycardia |
3.9% |
| Weight Increased |
3.9% |
| Grand Mal Convulsion |
2.9% |
| Activation Syndrome |
1.9% |
| Convulsion |
1.9% |
| Nausea |
1.9% |
| Cardiomyopathy |
1.0% |
| Depressive Symptom |
1.0% |
| Drug Ineffective |
1.0% |
| Drug Toxicity |
1.0% |
| Hypokalaemia |
1.0% |
| Injury |
1.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
13.5% |
| Insomnia |
9.8% |
| Depression |
8.8% |
| Rheumatoid Arthritis |
8.4% |
| Hiv Infection |
8.2% |
| Fibromyalgia |
5.7% |
| Constipation |
5.5% |
| Product Used For Unknown Indication |
4.9% |
| Schizophrenia |
4.7% |
| Major Depression |
4.1% |
| Hypertension |
3.9% |
| Hepatitis C |
2.9% |
| Bipolar Ii Disorder |
2.7% |
| Gastritis |
2.7% |
| Prophylaxis |
2.7% |
| Diabetes Mellitus |
2.5% |
| Headache |
2.3% |
| Postoperative Care |
2.3% |
| Bipolar Disorder |
2.2% |
| Adverse Event |
2.0% |
|
| Somnolence |
9.1% |
| Vertigo Positional |
9.1% |
| Drug Ineffective |
7.6% |
| Rheumatoid Arthritis |
7.6% |
| Malaise |
6.1% |
| Pain |
6.1% |
| Enterocolitis |
4.5% |
| Femoral Neck Fracture |
4.5% |
| Hepatic Function Abnormal |
4.5% |
| Nausea |
4.5% |
| Pneumonia |
4.5% |
| Renal Failure Acute |
4.5% |
| Restlessness |
4.5% |
| Weight Decreased |
4.5% |
| Anaphylactic Shock |
3.0% |
| Aphasia |
3.0% |
| Convulsion |
3.0% |
| Dizziness |
3.0% |
| Drug Eruption |
3.0% |
| Gastric Cancer |
3.0% |
|
| Interacting |
| Fibromyalgia |
28.0% |
| Myofascial Pain Syndrome |
28.0% |
| Arthralgia |
14.0% |
| Blood Cholesterol Increased |
4.3% |
| Chronic Obstructive Pulmonary Disease |
4.3% |
| Hypertension |
4.3% |
| Muscle Relaxant Therapy |
4.3% |
| Seasonal Allergy |
4.3% |
| Sleep Disorder |
4.3% |
| Smoking Cessation Therapy |
4.3% |
|
| Serotonin Syndrome |
73.1% |
| Drug Ineffective |
15.4% |
| Oedema Peripheral |
11.5% |
|
